Alexion Pharmaceuticals Inc., of Cheshire, Conn., reported that first quarter net product sales increased 67 percent to $566.6 million, compared to $338.9 million in the same period last year. Excluding the impact of $87.8 million for reimbursement of prior year shipments, net product sales went up 41 percent to $478.8 million.